Atorvastatin Genericon 20 mg filmom obložene tablete
| Name | Atorvastatin Genericon 20 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-023131915 |
| Active Substance | atorvastatinkalcij trihidrat |
| Composition | svaka filmom obložena tableta sadrži 20 mg atorvastatina u obliku atorvastatinkalcijevog trihidrata |
| Pharmaceutical Form | Filmom obložena tableta |
| Packaging [MA Number for Packaging] | 4 tablete u blisteru, u kutiji [HR-H-023131915-01] 7 tableta u blisteru, u kutiji [HR-H-023131915-02] 10 tableta u blisteru, u kutiji [HR-H-023131915-03] 14 tableta u blisteru, u kutiji [HR-H-023131915-04] 20 tableta u blisteru, u kutiji [HR-H-023131915-05] 28 tableta u blisteru, u kutiji [HR-H-023131915-06] 30 tableta u blisteru, u kutiji [HR-H-023131915-07] 50 tableta u blisteru, u kutiji [HR-H-023131915-08] 56 tableta u blisteru, u kutiji [HR-H-023131915-09] 84 tablete u blisteru, u kutiji [HR-H-023131915-10] 90 tableta u blisteru, u kutiji [HR-H-023131915-11] 98 tableta u blisteru, u kutiji [HR-H-023131915-12] 100 tableta u blisteru, u kutiji [HR-H-023131915-13] |
| Manufacturer | Genericon Pharma Gesellschaft m.b.H., Graz, Austrija
Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska |
| Marketing Authorisation Holder | Genericon Pharma Gesellschaft m.b.H., Hafnerstraße 211, Graz, Austrija |
| Marketing Authorisation Date | 14.11.2022 |
| MA Period of Validity | 14.11.2027 |
| Classification Number | UP/I-530-09/21-01/12 |
| Registration Number | 381-12-01/70-22-06 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C10AA05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
